These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11203054)

  • 1. [Consumption of drugs: policies and social pact].
    Antoñanzas Villar F
    Gac Sanit; 2000; 14(2):93-6. PubMed ID: 11203054
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug utilization decisions should be based on cost-benefit data].
    Bengt J; Arvidsson G; Levin LA; Rehnberg C
    Lakartidningen; 2005 Apr 18-24; 102(16):1264-5; discussion 1265. PubMed ID: 15921102
    [No Abstract]   [Full Text] [Related]  

  • 3. [Measures to contain drug costs and quality indicators in the use of drugs: prescribe less or prescribe better?].
    Arnau JM
    Aten Primaria; 1994 Mar; 13(4):155-8. PubMed ID: 8180298
    [No Abstract]   [Full Text] [Related]  

  • 4. [We don't prescribe the most expensive drugs, but we have the lowest costs!].
    Hemberg P
    Lakartidningen; 2002 Mar; 99(10):1094-5. PubMed ID: 12024788
    [No Abstract]   [Full Text] [Related]  

  • 5. Rational drug use. Part I: The role of national drug policies.
    Manyemba J; Dzuda C; Nyazema NZ
    Cent Afr J Med; 2000 Aug; 46(8):229-32. PubMed ID: 11317597
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug committees should be abolished because the reality has changed].
    Jönsson B; Arvidsson G; Levin LA; Rehnberg C
    Lakartidningen; 2005 Mar 14-20; 102(11):880-1; discussion 882-3. PubMed ID: 15835525
    [No Abstract]   [Full Text] [Related]  

  • 7. The rising utilization and costs of prescription drugs.
    PHC4 FYI; 2004; (26):1-2. PubMed ID: 15344277
    [No Abstract]   [Full Text] [Related]  

  • 8. [Correct drug utilization--a national economy perspective].
    Jørgensen E
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):934. PubMed ID: 16554889
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cost-effective drug utilization--what can the national drug agency do?].
    Wesenberg GR; Madsen S
    Tidsskr Nor Laegeforen; 2001 Aug; 121(18):2207. PubMed ID: 11572010
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs still influence health costs, but trend abating.
    Capitation Rates Data; 2003 Oct; 8(10):114-20. PubMed ID: 14621548
    [No Abstract]   [Full Text] [Related]  

  • 11. [Economic prescription of drugs].
    Sonne J; Faber O
    Ugeskr Laeger; 2004 Apr; 166(18):1695. PubMed ID: 15174414
    [No Abstract]   [Full Text] [Related]  

  • 12. [Choice of drugs--by whom, for whom and to what costs?].
    Frisk M; Strömstedt A
    Lakartidningen; 2000 Sep; 97(39):4343-6. PubMed ID: 11076479
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is it correct to receive a bonus in connection with drug prescription?].
    Olsson S
    Lakartidningen; 2002 May; 99(20):2331; author reply 2331. PubMed ID: 12082958
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescription drugs: recent trends in utilization, expenditures, and coverage.
    Sethi RC
    EBRI Issue Brief; 2004 Jan; (265):1-35. PubMed ID: 14969223
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antibiotics in Valencian Community: controlling expenditure but not consumption].
    Colomina-Rodríguez J; Gil-Tomás JJ; Pérez-Doñate V; Borrás-Máñez M
    Rev Esp Quimioter; 2014 Sep; 27(3):227-9. PubMed ID: 25229382
    [No Abstract]   [Full Text] [Related]  

  • 16. [Public health service prescriptions of vaccines not included in systematic vaccination programs in Valencian community, Spain, during the period 2004-2009].
    Ruiz Palacio A; Pastor Villalba E; Martín Ivorra R; Alguacil Ramos AM; Portero Alonso A; Lluch Rodrigo JA
    Rev Esp Salud Publica; 2011 Jun; 85(3):285-95. PubMed ID: 21892553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of drugs intake in aged people].
    Aizpuru K
    Rev Neurol; 1997 Jul; 25 Suppl 1():S73-5. PubMed ID: 9280672
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinton team works with drug companies to expand access, restrict costs.
    Am J Hosp Pharm; 1993 Mar; 50(3):388, 391. PubMed ID: 8442442
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drugs and cost-effectiveness].
    Marín Moreno S
    Med Clin (Barc); 2002 Mar; 118(11):438; author reply 438-9. PubMed ID: 11943110
    [No Abstract]   [Full Text] [Related]  

  • 20. PACT and audit.
    Heywood P
    Practitioner; 1991 Mar; 235(1500):268-9. PubMed ID: 1852711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.